Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
glucose 5% (50 g/L) + sodium chloride 0.9% (9 g/L) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin neutral human 50 units/mL + insulin isophane human 50 units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 4% (40 g/L) + sodium chloride 0.18% (1.8 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 4% (20 g/500 mL) + sodium chloride 0.18% (900 mg/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
tobramycin 20 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
furosemide 20 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 10% (50 g/500 mL) + sodium chloride 0.22% (1.1 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent adult vaccine 2011-2012 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 3.75% (18.75 g/500 mL) + sodium chloride 0.225% (1.125 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
furosemide 50 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
furosemide 250 mg/25 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 3.3% (16.5 g/500 mL) + sodium chloride 0.3% (1.5 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent child vaccine 2011-2012 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
furosemide 40 mg/4 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glucose 5% (25 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
palifermin 6.25 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydromorphone hydrochloride 2 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent adult vaccine 2011-2012 injection, 0.1 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydromorphone hydrochloride 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
varicella-zoster virus immunoglobulin 200 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
certolizumab pegol 200 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alglucosidase alfa 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
codeine phosphate 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
influenza child vaccine pandemic 2009, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
desmopressin acetate 4 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza multi-dose vaccine pandemic 2009 injection, 10 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
desmopressin acetate 15 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 2 g/250 mL + arginine 2.1 g/250 mL + aspartic acid 1.5 g/250 mL + cysteine 472.5 mg/250 mL + glutamic acid 2.5 g/250 mL + glycine 1 g/250 mL + histidine 950 mg/250 mL + isoleucine 1.675 g/250 mL + leucine 2.5 g/250 mL + lysine 2.75 g/250 mL + methionine 600 mg/250 mL + ornithine monohydrochloride 795 mg/250 mL + phenylalanine 1.05 g/250 mL + proline 750 mg/250 mL + serine 1 g/250 mL + taurine 150 mg/250 mL + threonine 925 mg/250 mL + tryptophan 500 mg/250 mL + tyrosine 112.5 mg/250 mL + valine 1.9 g/250 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 800 mg/100 mL + arginine 840 mg/100 mL + aspartic acid 600 mg/100 mL + cysteine 189 mg/100 mL + glutamic acid 1 g/100 mL + glycine 400 mg/100 mL + histidine 380 mg/100 mL + isoleucine 670 mg/100 mL + leucine 1 g/100 mL + lysine 1.1 g/100 mL + methionine 240 mg/100 mL + ornithine monohydrochloride 318 mg/100 mL + phenylalanine 420 mg/100 mL + proline 300 mg/100 mL + serine 400 mg/100 mL + taurine 60 mg/100 mL + threonine 370 mg/100 mL + tryptophan 200 mg/100 mL + tyrosine 45 mg/100 mL + valine 760 mg/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza adult vaccine pandemic 2009 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydromorphone hydrochloride 500 mg/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)v-like) inactivated vaccine 150 microgram / 5 mL injection, 5 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
liraglutide 18 mg/3 mL injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
pasireotide 600 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
Neorecormon 6000 units/0.3 mL injection, 0.3 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pasireotide 300 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
pasireotide 900 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
benzatropine mesilate 2 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 50 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
capreomycin 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
benzatropine mesilate 2 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 50 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 100 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 300 mg/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gentamicin 60 mg / 1.5 mL injection, 1.5 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gentamicin 80 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dacarbazine 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
dacarbazine 200 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 15 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gentamicin 40 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 100 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gentamicin 80 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gentamicin 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
folinic acid 1 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fluphenazine decanoate 50 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
retinol palmitate 690 microgram (2300 units)/10 mL + ergocalciferol 10 microgram (400 units)/10 mL + dl-alpha-tocopherol 6.4 mg (7 units)/10 mL + phytomenadione 200 microgram/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fluphenazine decanoate 12.5 mg/0.5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
thiamine hydrochloride 20 mg/2 mL + riboflavin sodium phosphate 5 mg/2 mL + nicotinamide 50 mg/2 mL + dexpanthenol 5 mg/2 mL + pyridoxine hydrochloride 10 mg/2 mL + cyanocobalamin 1 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
retinol palmitate 990 microgram (3300 units)/10 mL + ergocalciferol 5 microgram (200 units)/10 mL + dl-alpha-tocopherol 9.1 mg (10 units)/10 mL + phytomenadione 150 microgram/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
anecortave acetate 15 mg/0.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fluphenazine decanoate 25 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
meningococcal group A conjugate vaccine 10 microgram + meningococcal group C conjugate vaccine 5 microgram + meningococcal group W135 conjugate vaccine 5 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 5 microgram injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
gadoversetamide 9.93 g/30 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefotaxime 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 3.31 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
meningococcal group A conjugate vaccine 4 microgram + meningococcal group C conjugate vaccine 4 microgram + meningococcal group W135 conjugate vaccine 4 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 4 microgram injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
cefotaxime 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 1.65 g/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefotaxime 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 4.96 g/15 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 6.62 g/20 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 500 microgram/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 3.31 g/10 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
procaine benzylpenicillin 1.5 g/3.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 4.96 g/15 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 50 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadoversetamide 6.62 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 50 microgram/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 100 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 500 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
octreotide 100 microgram/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + Bordetella pertussis, acellular pertussis toxoid vaccine 25 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 25 microgram + Bordetella pertussis, acellular pertactin vaccine 8 microgram + hepatitis B vaccine 10 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
adenosine 30 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefazolin 1 g injection, 1 g vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
adenosine 6 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefazolin 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
haloperidol 5 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefazolin 2 g injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doripenem 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefazolin 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sugammadex 200 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sugammadex 500 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 10.35 g/L + arginine 5.75 g/L + glucose 250 g/L + glycine 5.65 g/L + histidine 2.4 g/L + isoleucine 3 g/L + leucine 3.65 g/L + lysine hydrochloride 2.9 g/L + magnesium (as chloride) 60.97 mg (magnesium 2.5 mmol)/L + methionine 2 g/L + phenylalanine 2.8 g/L + dibasic potassium phosphate 2.61 g (phosphorus 15 mmol + potassium 30 mmol)/L + proline 3.4 g/L + serine 2.5 g/L + sodium acetate trihydrate 3.4 g/L + sodium chloride 585 mg/L + threonine 2.1 g/L + tryptophan 900 mg/L + tyrosine 200 mg/L + valine 2.9 g/L injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
diazepam 10 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium gluconate 2.51 g/500 mL + sodium chloride 2.63 g/500 mL + potassium chloride 185 mg/500 mL + magnesium chloride 150 mg/500 mL + sodium acetate trihydrate 1.84 g/500 mL injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
sodium gluconate 5.02 g/L + sodium chloride 5.26 g/L + potassium chloride 370 mg (potassium 5 mmol)/L + magnesium chloride 300 mg (magnesium 1.5 mmol)/L + sodium acetate trihydrate 3.68 g/L injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
alanine 10.35 g/L + arginine 5.75 g/L + glucose 125 g/L + glycine 5.65 g/L + histidine 2.4 g/L + isoleucine 3 g/L + leucine 3.65 g/L + lysine hydrochloride 2.9 g/L + magnesium (as chloride) 60.97 mg (magnesium 2.5 mmol)/L + methionine 2 g/L + phenylalanine 2.8 g/L + dibasic potassium phosphate 2.61 g (phosphorus 15 mmol + potassium 30 mmol)/L + proline 3.4 g/L + serine 2.5 g/L + sodium acetate trihydrate 3.4 g/L + sodium chloride 585 mg/L + threonine 2.1 g/L + tryptophan 900 mg/L + tyrosine 200 mg/L + valine 2.9 g/L injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
nanoparticle albumin-bound paclitaxel 100 mg injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|